Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Bulletin Du Cancer
|
July 10, 2004
[Identification of prognostic factors in post-transplantation lymphoproliferative disorders]
Sylvain Choquet, Vincent Levy, Véronique Leblond
Contemporary Clinical Trials
|
March 20, 2024
Single-arm phase 3 designs: An oxymoron?
Aya Hussein, Vincent Levy, Sylvie Chevret
Bulletin Du Cancer
|
March 30, 2004
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma]
Carole Soussain, Khê Hoang-Xuan, Vincent Levy
The Lancet. Gastroenterology & Hepatology
|
February 14, 2021
Personalised dosimetry for SIRT: new standard or bridge to surgical resection?
Maxime Ronot, Vincent Levy, Jean-Charles Nault
Cancer
|
January 7, 2006
Factors influencing inclusion of patients with malignancies in clinical trials
Caroline Tournoux, Sandrine Katsahian, Sylvie Chevret, et al.
Journal of Critical Care
|
April 18, 2006
Methemoglobinemia and acute hemolysis after tetracaine lozenge use
Sandrine Lavergne, Michael Darmon, Vincent Levy, et al.
BMC Cancer
|
October 22, 2025
Therapeutic innovation in oncology: What do you mean? Whereof one cannot speak, thereof one must be silent, L. Wittgenstein
Sylvie Chevret, Xavier Troussard, Charlotte Masia, et al.
Journal of Clinical Microbiology
|
September 1, 1992
Evaluation of nonradioactive DNA probes for identification of mycobacteria
L Lebrun, F Espinasse, J D Poveda, et al.
Clinical Trials (London, England)
|
October 2, 2008
Quality assessment of phase I dose-finding cancer trials: proposal of a checklist
Sarah Zohar, Qing Lian, Vincent Levy, et al.
Haematologica
|
October 13, 2004
Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study
François Lefrère, Alain Delmer, Vincent Levy, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Bulletin Du Cancer
|
July 10, 2004
[Identification of prognostic factors in post-transplantation lymphoproliferative disorders]
Sylvain Choquet, Vincent Levy, Véronique Leblond
Contemporary Clinical Trials
|
March 20, 2024
Single-arm phase 3 designs: An oxymoron?
Aya Hussein, Vincent Levy, Sylvie Chevret
Bulletin Du Cancer
|
March 30, 2004
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma]
Carole Soussain, Khê Hoang-Xuan, Vincent Levy
The Lancet. Gastroenterology & Hepatology
|
February 14, 2021
Personalised dosimetry for SIRT: new standard or bridge to surgical resection?
Maxime Ronot, Vincent Levy, Jean-Charles Nault
Cancer
|
January 7, 2006
Factors influencing inclusion of patients with malignancies in clinical trials
Caroline Tournoux, Sandrine Katsahian, Sylvie Chevret, et al.
Journal of Critical Care
|
April 18, 2006
Methemoglobinemia and acute hemolysis after tetracaine lozenge use
Sandrine Lavergne, Michael Darmon, Vincent Levy, et al.
BMC Cancer
|
October 22, 2025
Therapeutic innovation in oncology: What do you mean? Whereof one cannot speak, thereof one must be silent, L. Wittgenstein
Sylvie Chevret, Xavier Troussard, Charlotte Masia, et al.
Journal of Clinical Microbiology
|
September 1, 1992
Evaluation of nonradioactive DNA probes for identification of mycobacteria
L Lebrun, F Espinasse, J D Poveda, et al.
Clinical Trials (London, England)
|
October 2, 2008
Quality assessment of phase I dose-finding cancer trials: proposal of a checklist
Sarah Zohar, Qing Lian, Vincent Levy, et al.
Haematologica
|
October 13, 2004
Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study
François Lefrère, Alain Delmer, Vincent Levy, et al.
Page
of 6